Imbio RV/LV Software vs Aorta-CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by Imagen Technologies

AI Verdict

Tool A is an AI-powered solution for automatically measuring right and left ventricular diameters from CTPA scans, primarily for pulmonary embolism risk stratification. Tool B, on the other hand, is an AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. While both are cardiology and radiology AI tools, their distinct imaging modalities and specific anatomical focus areas mean they address different clinical needs.

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if your clinical workflow involves frequent CTPA scans and you require automated, precise measurements of right and left ventricular diameters to rapidly assess for right heart strain, particularly in suspected pulmonary embolism cases. This tool is ideal for enhancing risk stratification and guiding urgent management decisions based on objective ventricular ratios.

View Imbio RV/LV Software →

Choose Aorta-CAD if…

Choose Aorta-CAD if your practice regularly utilizes chest X-rays and you need AI assistance in detecting subtle signs of Aortic Atherosclerosis and Aortic Ectasia that might be overlooked. This cloud-based solution is well-suited for improving the accuracy of routine chest X-ray interpretations, helping both radiologists and primary care physicians identify significant aortic findings for further investigation.

View Aorta-CAD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio RV/LV Software Aorta-CAD
Deployment Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers.
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio RV/LV Software Aorta-CAD
Name Imbio RV/LV Software Aorta-CAD
Company Imbio Imagen Technologies
Primary AI Function/Target Automated measurement of right and left ventricular diameters from CTPA scans for RV/LV ratio to aid in risk stratification for pulmonary conditions Detects signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays
Input Imaging Modality CTPA scans Chest X-rays
Key Output/Report Type Annotated images showing ventricular measurements, summary PDF reports Annotations via an overlay that can be toggled on/off
Specialties Supported Cardiology, Pulmonology, Radiology Cardiology, Internal Medicine, Radiology

Videos

Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and Aorta-CAD.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio RV/LV Software analyzes CTPA scans to measure right and left ventricular diameters. Aorta-CAD by Imagen Technologies analyzes chest X-rays to detect signs of Aortic Atherosclerosis and Aortic Ectasia.
Imbio RV/LV Software aids in risk stratification for pulmonary conditions like pulmonary embolism by providing an RV/LV ratio from CTPA scans. Aorta-CAD assists physicians in detecting radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays.
Imbio RV/LV Software provides automated measurements of RV/LV diameters, calculates and reports the RV/LV ratio, shows annotated images, and generates summary PDF reports. Aorta-CAD detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia, creating annotations via an overlay that can be toggled on/off.
Imbio RV/LV Software focuses on providing automated, consistent, and quantitative reporting of the RV/LV ratio to aid in risk stratification. Aorta-CAD has demonstrated a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in a clinical study.
AI Tool Finder
AI-powered search. Results may not be comprehensive.